
Pathogenesis and inflammaging in MDS [MDS Professional Report]
Feb 1, 2025 - 28:47
Radio and PodcastLive Radio & Podcasts![Do immune check inhibitors have a role in the treatment of higher-risk MDS? [MDS Professional Report] artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/7b8bc7d62bbbfefa1a0c2f97a3d163fe.jpg)
Chien Aza – Pembro - BJH The combination of azacitidine and pembrolizumab may be a potential effective regimen for patients with higher-risk MDS and may lead to the introduction of an important class of medications into...
Do immune check inhibitors have a role in the treatment of higher-risk MDS? [MDS Professional Report] is an episode from MDS Professional Report by PI Media. Chien Aza – Pembro - BJH The combination of azacitidine and pembrolizumab may be a...
This episode belongs to MDS Professional Report.
Use the player on this page to stream the episode online.
Published Sep 22, 2021, 23:44 long, audio available.